MSB 2.31% $1.16 mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-37

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    very, very good news!....confirmations of what we knew was coming...
    agree with most of the comments here except one - we do NOT need any partners now for this part of our business...they can all go and jump! a partner is needed to get through PH3 trials...not after all is done and dusted.....they were needed months ago.....the sells we will manage on our own , thank you very much...and keep ALL the profits....but this result and early to market approval may bring some interested parties for a look in at our other products/treatments in a pipeline.....they are welcome to join us for those....
    happy to wait some more for MSB to achieve it's full potential and attention....and well deserved...my money sitting here is my "patient" money...not needed anywhere else....cheers!.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
-0.028(2.31%)
Mkt cap ! $1.324B
Open High Low Value Volume
$1.18 $1.22 $1.15 $4.506M 3.822M

Buyers (Bids)

No. Vol. Price($)
25 38435 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 116326 11
View Market Depth
Last trade - 14.21pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.